Gamma Knife Market - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027
Gamma Knife |
Gamma Knife Devices are used to treat a variety of
conditions, including meningiomas, tumours on the protective layers of the
brain, vascular malformations of the brain, acoustic neuromas, trigeminal
neuralgia, which causes excruciating facial agony, and temporal lobe epilepsy.
During the forecast period, the Gamma Knife Market is anticipated to expand at a considerable CAGR.
By entering new markets, market participants are increasing their market
presence. For example, Elekta got a medical devices licence from Health Canada
in February 2017 for its Leksell Gamma Knife Icon radiosurgery system, the only
stereotactic radio surgery (SRS) system created particularly to target brain
tissue. The market players use new product releases and product developments as
marketing methods. One sort of radiological surgery tool is the gamma knife,
which works by concentrating precise targets with low-dose gamma radiation from
a variety of sources.
The demand for minimally invasive procedures, rising rates of
brain cancer, and an ageing global population are driving the Gamma
Knife Market. Additionally, a high gamma knife treatment success
rate, a quick recovery time, advantageous health insurance policies,
significant government initiatives, and rising radiation therapy awareness are
projected to drive the market. However, the market is anticipated to be
hampered by strict restrictions for the certification of radiation devices,
high costs for gamma knife equipment, and a lack of awareness in developing
regions.
According To Coherent
Market Insights, The Global Gamma Knife Market Is Estimated To Be Valued At US$
215.8 Million In 2020 And Is Expected To Exhibit A CAGR Of 4.5% During The
Forecast Period (2020-2027).
Cyber knife, linac radiosurgery, traditional brain surgery,
proton treatment, and customised linear accelerators are just a few of the
alternative therapies that use gamma knives. Additionally, radiation therapy
side effects and a lack of qualified medical personnel to use the radiation
equipment are limiting the market's expansion.
The Gamma Knife Market
is being driven by the rising demand for minimally invasive procedures, a
growth in brain cancer prevalence, and an ageing global population. In
addition, the market is expected to be boosted by the high success rate of
gamma knife treatments, quick recovery times, good health insurance policies,
significant government initiatives, and rising radiation therapy awareness.
However, strict guidelines for radiation device certification,
expensive gamma knife equipment costs, and a lack of knowledge in developing
nations are anticipated to stymie the industry. Proton treatment, cyber knife,
linac radiosurgery, traditional brain surgery, modified linear accelerators,
and gamma knife are just a few of the alternative therapies that use this
instrument. Additionally,
radiation therapy side effects and a lack of qualified medical personnel to use
the radiation equipment are limiting the market's expansion.
Additionally, radiation therapy side effects and a lack of
qualified medical personnel to use the radiation equipment are limiting the Gamma Knife Market expansion.
Top Companies involved
are- Elekta AB,
American Radiosurgery Inc., and Masep Medical Science & Technology
Development Co., Ltd.
Comments
Post a Comment